PROPKD Score

Predict renal survival in Autosomal Dominant Polycystic Kidney Disease (ADPKD) using genetics

About

The course of renal outcomes in autosomal dominant polycystic kidney disease (ADPKD) is quite variable with some reaching end stage renal disease early in life and others never reaching it at all. The PROPKD score is a prognostic score that accurately predicts renal outcomes in patients with ADPKD which may assist with clinical decision making in these patients.

The PROPKD score can only be used in individuals over 35 years of age or in patients younger than 35 if they have both a urologic event before 35 years and onset of hypertension before age 35. If patients do not meet the criteria for use of the PROPKD score, other prognostic scoring systems can be used or the individual clinical risk factors and/or genotype can provide some predictive value although this is less accurate than the complete scoring system.

The PROPKD scoring system was developed from a multivariate survival analysis that identified the four variables associated with renal survival that are used to calculate the score. Derivation of the scoring system included data from 1341 individuals from 913 pedigrees across multiple centres in France.

References

Cornec-Le Gall E, Audrezet M-P, Rousseau A, Hourmant M, Renaudineau E, Charasse C, et al.

The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology: JASN 2016, 27 (3): 942-51

The PROPKD Score calculator is created by QxMD.

Created by on 12/06/2016

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. Does the Patient Meet These Criteria?

More Information

The PROPKD score can only be used in individuals over 35 years of age
or
in patients younger than 35, if they have both a urologic event before 35 years and onset of hypertension before age 35

0/5 completed